|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 145 | 13 | 9.0 | 39 | 26.9 | 62 | 42.8 | 20 | 13.8 | 11 | 7.6 |
| 2015-2019 | 144 | 9 | 6.3 | 41 | 28.5 | 59 | 41.0 | 21 | 14.6 | 14 | 9.7 |
| 2014-2018 | 130 | 10 | 7.7 | 39 | 30.0 | 48 | 36.9 | 22 | 16.9 | 11 | 8.5 |
| 2013-2017 | 135 | 9 | 6.7 | 39 | 28.9 | 50 | 37.0 | 22 | 16.3 | 15 | 11.1 |
| 2012-2016 | 111 | 4 | 3.6 | 34 | 30.6 | 42 | 37.8 | 19 | 17.1 | 12 | 10.8 |
| 2011-2015 | 106 | 3 | 2.8 | 36 | 34.0 | 31 | 29.2 | 26 | 24.5 | 10 | 9.4 |
| 2010-2014 | 104 | 5 | 4.8 | 35 | 33.7 | 29 | 27.9 | 28 | 26.9 | 7 | 6.7 |
| 2009-2013 | 99 | 2 | 2.0 | 34 | 34.3 | 29 | 29.3 | 27 | 27.3 | 7 | 7.1 |
| 2008-2012 | 113 | 4 | 3.5 | 43 | 38.1 | 31 | 27.4 | 27 | 23.9 | 8 | 7.1 |
| 2007-2011 | 125 | 5 | 4.0 | 41 | 32.8 | 35 | 28.0 | 33 | 26.4 | 11 | 8.8 |
| 2006-2010 | 131 | 6 | 4.6 | 37 | 28.2 | 46 | 35.1 | 27 | 20.6 | 15 | 11.5 |
| 2005-2009 | 135 | 8 | 5.9 | 40 | 29.6 | 44 | 32.6 | 25 | 18.5 | 18 | 13.3 |
| 2004-2008 | 145 | 10 | 6.9 | 42 | 29.0 | 48 | 33.1 | 25 | 17.2 | 20 | 13.8 |
| 2003-2007 | 135 | 9 | 6.7 | 35 | 25.9 | 49 | 36.3 | 24 | 17.8 | 18 | 13.3 |
| 2002-2006 | 132 | 8 | 6.1 | 37 | 28.0 | 49 | 37.1 | 18 | 13.6 | 20 | 15.2 |
| 2001-2005 | 121 | 7 | 5.8 | 39 | 32.2 | 38 | 31.4 | 18 | 14.9 | 19 | 15.7 |
| 2000-2004 | 118 | 3 | 2.5 | 37 | 31.4 | 40 | 33.9 | 19 | 16.1 | 19 | 16.1 |
| 1999-2003 | 118 | 1 | 0.8 | 38 | 32.2 | 41 | 34.7 | 18 | 15.3 | 20 | 16.9 |
| 1998-2002 | 118 | 1 | 0.8 | 35 | 29.7 | 44 | 37.3 | 17 | 14.4 | 21 | 17.8 |
| 1997-2001 | 119 | 2 | 1.7 | 39 | 32.8 | 41 | 34.5 | 22 | 18.5 | 15 | 12.6 |
| 1996-2000 | 122 | 3 | 2.5 | 40 | 32.8 | 44 | 36.1 | 21 | 17.2 | 14 | 11.5 |
| 1995-1999 | 110 | 3 | 2.7 | 35 | 31.8 | 41 | 37.3 | 20 | 18.2 | 11 | 10.0 |
| 1994-1998 | 122 | 3 | 2.5 | 35 | 28.7 | 53 | 43.4 | 21 | 17.2 | 10 | 8.2 |
| 1993-1997 | 119 | 3 | 2.5 | 38 | 31.9 | 46 | 38.7 | 22 | 18.5 | 10 | 8.4 |
| 1992-1996 | 120 | 3 | 2.5 | 34 | 28.3 | 54 | 45.0 | 19 | 15.8 | 10 | 8.3 |
| 1991-1995 | 119 | 3 | 2.5 | 30 | 25.2 | 54 | 45.4 | 22 | 18.5 | 10 | 8.4 |
| 1990-1994 | 130 | 5 | 3.8 | 33 | 25.4 | 54 | 41.5 | 24 | 18.5 | 14 | 10.8 |
| 1989-1993 | 118 | 7 | 5.9 | 32 | 27.1 | 37 | 31.4 | 24 | 20.3 | 18 | 15.3 |
| 1988-1992 | 128 | 7 | 5.5 | 30 | 23.4 | 43 | 33.6 | 24 | 18.8 | 24 | 18.8 |
| 1987-1991 | 130 | 7 | 5.4 | 31 | 23.8 | 41 | 31.5 | 23 | 17.7 | 28 | 21.5 |
| 1986-1990 | 133 | 6 | 4.5 | 36 | 27.1 | 41 | 30.8 | 22 | 16.5 | 28 | 21.1 |
| 1985-1989 | 138 | 4 | 2.9 | 38 | 27.5 | 45 | 32.6 | 25 | 18.1 | 26 | 18.8 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |